Distinct Mechanisms of Lysophosphatidic Acid in Ovarian Cancer Cells

Strategic Insights -

Researchers in the United States have found that lysophosphatidic acid (LPA) plays a critical role in the initiation and progression of ovarian cancer. LPA is an autocrine growth signal that stimulates cell growth through distinct mechanisms in two ovarian cancer cell lines, SKOV-3 and Caov-3. The study, published in Pharmacology, reveals that the receptors and signaling cascades responsible for mediating LPA-stimulated cell growth differ between the two cell lines.

Key Takeaways:

  • LPA is an autocrine growth signal critical to the initiation and progression of ovarian cancer.
  • Distinct agonist pharmacological profiles were observed in SKOV-3 and Caov-3 cells, with saturated and unsaturated LPA species having different potencies.
  • The LPA1/LPA3 receptor antagonist Ki16425 was more potent in SKOV-3 cells, while saturated LPA was less potent than unsaturated LPA in SKOV-3 cells.
  • The effect of LPA on cell growth in both cell lines was dependent on phosphatidylinositol-3 kinases and MAP kinases.
  • LPA-stimulated cell growth in SKOV-3 cells required Gi G proteins, while Caov-3 cell growth was dependent on the Rho effector p160 Rho kinase.
  • Regulator of G protein signaling proteins regulated Gi-dependent LPA-stimulated cell growth in SKOV-3 cells.
  • The researchers concluded that LPA-stimulated cell growth is mediated by distinct but overlapping receptors and signaling pathways in these two model ovarian cancer cell lines.

Statistics:

  • 2 ovarian cancer cell lines (SKOV-3 and Caov-3) were used in the study.
  • Saturated and unsaturated LPA species were equally potent in Caov-3 cells, but saturated LPA was less potent than unsaturated LPA in SKOV-3 cells.
  • The LPA1/LPA3 receptor antagonist Ki16425 was more potent in SKOV-3 cells.
  • 70% of ovarian cancer patients experience a relapse, with the majority of those relapses occurring within 2 years.

Sources:

  • Hurst, J. H., et al. (2009). Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways. Pharmacology, 83(6), 333-347.
  • Ovarian Cancer Cell Biology.